HER2/NEU POSITIVE
Clinical trials for HER2/NEU POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU POSITIVE trials appear
Sign up with your email to follow new studies for HER2/NEU POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy for seniors with aggressive breast cancer shows promise in early trial
Disease control OngoingThis phase 2 trial is testing how well older adults (60+) with advanced HER2+ breast cancer tolerate a combination of two targeted drugs: lapatinib and trastuzumab. The study enrolled 40 participants and focuses on side effects, especially heart-related issues and severe toxiciti…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug Z-Endoxifen shows promise in early breast cancer trial
Disease control OngoingThis early-phase trial tested a drug called Z-endoxifen in 62 people with a type of breast cancer that has spread or come back. The goal was to find the safest dose and check for side effects. Z-endoxifen works by blocking estrogen, which some breast cancers need to grow.
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC